UPDATE : Monday, September 7, 2020
상단여백
‘Biosimilars are better than originals’ by Park Gi-taek 2018-05-16 15:56
Will Deloitte’s prediction of clinical success work? by Park Gi-taek 2018-05-03 13:12
Gastric cancer drug Cyramza to get insurance benefit by Park Gi-taek 2018-04-25 11:11
Obesity guidelines set anew in 3 stages by Park Gi-taek 2018-04-11 16:45
Medical equipment makers feel threatened by ‘Mooncare’ by Park Gi-taek 2018-03-27 16:39
라인
Why is biopharmaceutical outlook rosy, despite bubble concern? by Park Gi-taek 2018-03-21 16:04
Will restructuring wind sweep the domestic pharmaceutical industry? by Park Gi-taek 2018-03-16 18:29
Korea Otsuka not listening to sexual abuse victim by Park Gi-taek 2018-01-19 15:58
‘VIVIX, innovative flat panel detector for radiography’ by Park Gi-taek 2018-01-03 06:30
‘More accurate diagnosis of preeclampsia possible’ by Park Gi-taek 2017-12-14 11:38
라인
Secrets of ezCaretech’s overseas expansion success by Park Gi-taek 2017-12-08 15:09
Korea’s healthcare exports to reach $11.7 billion this year by Park Gi-taek 2017-12-07 14:10
‘Treatment of atopic dermatitis enhances kids’ mental health’ by Park Gi-taek 2017-11-30 16:22
Novartis Korea mired in sexual harassment scandal by Park Gi-taek 2017-11-29 14:58
‘Oral anticoagulants will be widely used for specific atrial fibrillation patients’ by Park Gi-taek 2017-10-19 06:30
라인
Former MFDS officials enjoy parachute positions: lawmaker by Park Gi-taek 2017-10-17 16:05
‘AstraZeneca’s lung cancer drug may not get insurance coverage’ by Park Gi-taek 2017-10-13 14:02
Experts grade on Vemlidy, new treatment for hepatitis B by Park Gi-taek 2017-10-10 10:53
Social, economic cost of COPD reaches ₩1.4 trillion a year by Park Gi-taek 2017-09-27 14:09
Oncolytic virotherapy association launched in Korea by Park Gi-taek 2017-09-22 16:13
여백
여백
여백
Back to Top